AngioDynamics, Inc. (ANGO) EBITDA
- 2026-02-28: Basis Reported; EBITDA (m); Operating income -$12.95M; Depreciation and amortization (m).
- 2025-11-30: Basis Reported; EBITDA (m); Operating income -$6.13M; Depreciation and amortization (m).
- 2025-08-31: Basis Reported; EBITDA (m); Operating income -$10.66M; Depreciation and amortization (m).
- 2025-02-28: Basis Reported; EBITDA (m); Operating income -$9.97M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-28 | Reported | (m) | -$12.95M | (m) | $78.42M | (m) | $1.01M* | -$3.11M* | $36.94M | $7.08M | (m) | $12.00K |
| 2025-11-30 | Reported | (m) | -$6.13M | (m) | $79.43M | (m) | $422.00K* | $4.66M* | $34.65M | $7.77M | (m) | -$5.00K |
| 2025-08-31 | Reported | (m) | -$10.66M | (m) | $75.71M | (m) | $731.00K | -$15.91M | $33.85M | $6.42M | (m) | $65.00K |
| 2025-02-28 | Reported | (m) | -$9.97M | (m) | $72.00M | (m) | $1.80M* | -$13.16M* | $33.15M | $6.91M | (m) | -$2.00K |
| 2024-11-30 | Reported | (m) | -$11.09M | (m) | $72.84M | (m) | $797.00K* | $2.47M* | $32.94M | $6.43M | (m) | -$110.00K |
| 2024-08-31 | Reported | (m) | -$13.10M | (m) | $67.49M | (m) | $1.09M | -$18.25M | $30.77M | $6.29M | (m) | $133.00K |
| 2024-02-29 | Reported | (m) | -$199.90M | (m) | $75.18M | (m) | $607.00K* | -$12.53M* | $39.32M | $8.19M | (m) | -$12.00M |
| 2023-11-30 | Reported | (m) | -$13.12M | (m) | $79.07M | (m) | $554.00K* | $5.27M* | $38.81M | $8.66M | (m) | $16.43M |
| 2023-08-31 | Reported | (m) | $35.03M | (m) | $78.68M | (m) | $791.00K | -$25.90M | $38.62M | $7.94M | (m) | -$11.02M |
| 2023-02-28 | Reported | (m) | -$8.93M | (m) | $80.71M | (m) | $666.00K* | $1.37M* | $40.21M | $6.85M | (m) | -$179.00K |
| 2022-11-30 | Reported | (m) | -$8.12M | (m) | $85.43M | (m) | $1.28M* | $7.50M* | $40.35M | $6.84M | (m) | -$565.00K |
| 2022-08-31 | Reported | (m) | -$13.30M | (m) | $81.54M | (m) | $809.00K | -$24.75M | $39.23M | $8.33M | (m) | -$853.00K |
| 2022-02-28 | Reported | (m) | -$5.29M | (m) | $73.97M | (m) | $1.11M* | -$8.79M* | $35.39M | $7.28M | (m) | -$799.00K |
| 2021-11-30 | Reported | (m) | -$8.68M | (m) | $78.28M | (m) | $1.13M* | $1.94M* | $37.73M | $8.20M | (m) | -$512.00K |
| 2021-08-31 | Reported | (m) | -$8.10M | (m) | $76.97M | (m) | $1.02M | -$8.90M | $36.83M | $7.39M | (m) | -$1.64M |
| 2021-02-28 | Reported | (m) | -$3.74M | (m) | $71.18M | (m) | $1.38M* | $5.87M* | $32.65M | $8.56M | (m) | -$583.00K |
| 2020-11-30 | Reported | (m) | -$4.84M | (m) | $72.77M | (m) | $1.36M* | $11.45M* | $32.60M | $9.71M | (m) | -$905.00K |
| 2020-08-31 | Reported | (m) | -$5.12M | (m) | $70.22M | (m) | $1.82M | -$5.42M | $34.45M | $9.01M | (m) | -$545.00K |
| 2020-02-29 | Reported | (m) | -$6.24M | (m) | (m) | (m) | $1.74M* | -$17.84M* | $29.48M | $8.39M | (m) | -$824.00K |
| 2019-11-30 | Reported | (m) | -$3.42M | (m) | (m) | (m) | $2.62M* | $5.94M* | $28.46M | $7.76M | (m) | -$566.00K |
| 2019-08-31 | Reported | (m) | -$828.00K | (m) | (m) | (m) | $1.39M | -$6.53M | $27.82M | $6.29M | (m) | -$116.00K |
| 2019-02-28 | Reported | (m) | -$3.67M | (m) | (m) | (m) | $887.00K* | $8.34M* | $27.36M | $6.92M | (m) | -$773.00K |
| 2018-11-30 | Reported | (m) | -$2.53M | (m) | (m) | (m) | $734.00K* | $12.96M* | $29.43M | $7.08M | (m) | -$190.00K |
| 2018-08-31 | Reported | (m) | -$6.13M | (m) | (m) | (m) | $682.00K | -$8.87M | $27.99M | $7.37M | (m) | -$1.23M |
| 2018-02-28 | Reported | (m) | $4.86M | (m) | (m) | (m) | $425.00K* | (m) | $38.40M | $6.46M | (m) | -$9.95M |
| 2017-11-30 | Reported | (m) | $1.12M | (m) | (m) | (m) | $721.00K* | (m) | $43.98M | $6.11M | (m) | -$166.00K |
| 2017-08-31 | Reported | (m) | $140.00K | (m) | (m) | (m) | $501.00K | (m) | $44.18M | $6.44M | (m) | $19.00K |
| 2017-02-28 | Reported | (m) | $5.14M | (m) | (m) | (m) | $412.00K* | (m) | (m) | $5.95M | (m) | $1.67M |
| 2016-11-30 | Reported | (m) | $15.59M | (m) | (m) | (m) | $1.36M* | (m) | (m) | $5.91M | (m) | $681.00K |
| 2016-08-31 | Reported | (m) | $3.57M | (m) | (m) | (m) | $481.00K | (m) | (m) | $6.71M | (m) | $1.60M |
| 2016-02-29 | Reported | (m) | $1.97M | (m) | (m) | (m) | $727.00K* | $12.39M* | (m) | $5.81M | (m) | $351.00K |
| 2015-11-30 | Reported | (m) | $565.00K | (m) | (m) | (m) | $425.00K* | $9.58M* | (m) | $6.18M | (m) | -$337.00K |
| 2015-08-31 | Reported | (m) | $212.00K | (m) | (m) | (m) | $743.00K | $4.70M | (m) | $6.13M | (m) | $70.00K |
| 2015-05-31 | Reported | (m) | $1.13M | (m) | (m) | (m) | (m) | (m) | (m) | $6.55M | (m) | $740.00K |
| 2015-02-28 | Reported | (m) | -$10.42M | (m) | (m) | (m) | $3.52M* | $12.23M* | (m) | $6.58M | (m) | -$7.60M |
| 2014-11-30 | Reported | (m) | $3.54M | (m) | (m) | (m) | $2.42M* | -$2.29M* | (m) | $6.28M | (m) | $1.30M |
| 2014-08-31 | Reported | (m) | $2.30M | (m) | (m) | (m) | $5.10M | $4.94M | (m) | $7.19M | (m) | $812.00K |
| 2014-05-31 | Reported | (m) | $3.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.33M |
| 2014-02-28 | Reported | (m) | $6.51M | (m) | (m) | (m) | $1.81M* | -$584.00K* | (m) | $7.04M | (m) | $28.00K |
| 2014-02-28 | Reported | (m) | $7.57M | (m) | (m) | (m) | (m) | (m) | (m) | $7.04M | (m) | $476.00K |
| 2013-11-30 | Reported | (m) | $1.44M | (m) | (m) | (m) | $4.29M* | $8.46M* | (m) | $7.00M | (m) | -$89.00K |
| 2013-08-31 | Reported | (m) | $1.40M | (m) | (m) | (m) | $2.90M | $7.30M | (m) | $6.71M | (m) | -$190.00K |
| 2013-02-28 | Reported | (m) | $58.00K | (m) | (m) | (m) | (m) | (m) | (m) | $5.79M | (m) | -$829.00K |
| 2013-02-28 | Reported | (m) | $58.00K | (m) | (m) | (m) | $2.92M* | $10.00M* | (m) | $5.79M | (m) | -$829.00K |
| 2012-11-30 | Reported | (m) | $5.12M | (m) | (m) | (m) | (m) | (m) | (m) | $7.01M | (m) | $1.16M |
| 2012-08-31 | Reported | (m) | $684.00K | (m) | (m) | (m) | $968.00K | -$5.61M | (m) | $7.07M | (m) | -$433.00K |
| 2012-08-31 | Reported | (m) | $1.40M | (m) | (m) | (m) | $968.00K | -$5.61M | (m) | $7.07M | (m) | -$190.00K |
| 2012-02-29 | Reported | (m) | -$2.76M | (m) | (m) | (m) | $821.00K* | $6.79M* | (m) | $4.57M | (m) | -$1.11M |
| 2011-11-30 | Reported | (m) | $3.93M | (m) | (m) | (m) | $517.00K* | $2.67M* | (m) | $5.13M | (m) | $1.24M |
| 2011-08-31 | Reported | (m) | $2.72M | (m) | (m) | (m) | $541.00K | $3.04M | (m) | $5.59M | (m) | $730.00K |
| 2011-02-28 | Reported | (m) | $5.25M | (m) | (m) | (m) | $483.00K* | $10.35M* | (m) | $5.32M | (m) | $1.26M |
| 2010-11-30 | Reported | (m) | $5.40M | (m) | (m) | (m) | $827.00K* | $9.89M* | (m) | $5.26M | (m) | $1.86M |
| 2010-08-31 | Reported | (m) | $3.48M | (m) | (m) | (m) | $662.00K | $1.74M | (m) | $5.24M | (m) | $1.06M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | Reported | (m) | -$39.93M | (m) | $320.17M | (m) | $2.58M | $3.09M | $145.28M | $29.45M | (m) | $442.00K |
| 2025-05-31 | Reported | (m) | -$39.95M | (m) | $292.50M | (m) | $4.46M | -$10.13M | $134.79M | $26.22M | (m) | -$39.00K |
| 2024-05-31 | Reported | (m) | -$192.44M | (m) | $303.91M | (m) | $2.52M | -$28.16M | $149.22M | $31.51M | (m) | -$7.29M |
| 2023-05-31 | Reported | (m) | -$51.18M | (m) | $338.75M | (m) | $3.81M | $78.00K | $164.51M | $29.88M | (m) | -$2.00M |
| 2022-05-31 | Reported | (m) | -$28.47M | (m) | $316.22M | (m) | $4.30M | -$7.19M | $150.49M | $30.74M | (m) | -$3.40M |
| 2021-05-31 | Reported | (m) | -$35.28M | (m) | $291.01M | (m) | $5.19M | $24.09M | $134.22M | $36.39M | (m) | -$4.50M |
| 2020-05-31 | Reported | (m) | -$167.10M | (m) | $264.16M | (m) | $7.24M | -$14.55M | $113.89M | $29.68M | (m) | -$1.35M |
| 2019-05-31 | Reported | (m) | -$9.40M | (m) | (m) | (m) | $3.12M | $37.44M | $114.63M | $28.26M | (m) | -$3.56M |
| 2018-05-31 | Reported | (m) | -$14.17M | (m) | (m) | (m) | $2.39M | $41.29M | $117.80M | $24.34M | (m) | -$11.04M |
| 2017-05-31 | Reported | (m) | -$11.18M | (m) | (m) | (m) | $3.00M | $55.74M | $125.84M | $24.15M | (m) | -$7.24M |
| 2016-05-31 | Reported | (m) | $1.02M | (m) | (m) | (m) | $2.33M | $45.22M | $179.57M | $25.05M | (m) | $40.34M |
| 2016-02-29 | Rolling | (m) | $3.87M* | (m) | (m) | (m) | (m) | (m) | (m) | $24.67M* | (m) | $824.00K* |
| 2015-11-30 | Rolling | (m) | -$8.52M* | (m) | (m) | (m) | (m) | (m) | (m) | $25.44M* | (m) | -$7.13M* |
| 2015-08-31 | Rolling | (m) | -$5.54M* | (m) | (m) | (m) | (m) | (m) | (m) | $25.53M* | (m) | -$5.49M* |
| 2015-05-31 | Reported | (m) | -$3.45M | (m) | (m) | (m) | $11.38M | $25.68M | (m) | $26.59M | (m) | -$4.74M |
| 2015-05-31 | Rolling | (m) | -$3.45M* | (m) | (m) | (m) | (m) | (m) | (m) | $26.59M* | (m) | -$4.74M* |
| 2015-02-28 | Rolling | (m) | -$994.00K* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -$2.16M* |
| 2014-05-31 | Reported | (m) | $10.49M | (m) | (m) | (m) | $11.17M | $24.68M | (m) | $28.12M | (m) | -$9.20M |
| 2013-05-31 | Reported | (m) | $5.24M | (m) | (m) | (m) | $12.12M | $26.65M | (m) | $26.09M | (m) | -$286.00K |
| 2012-05-31 | Reported | (m) | -$5.24M | (m) | (m) | (m) | $2.49M | $11.60M | (m) | $20.51M | (m) | -$322.00K |
| 2011-05-31 | Reported | (m) | $11.90M | (m) | (m) | (m) | $2.96M | $33.87M | (m) | $21.37M | (m) | $2.56M |
| 2010-05-31 | Reported | (m) | $20.87M | (m) | (m) | (m) | $5.04M | $39.96M | (m) | $19.27M | (m) | $7.31M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |